May 23, 2023

For more than 30 years, umbilical cord blood (UCB) has been an important stem cell source for patients with leukemia, lymphoma and MDS

May 02, 2023

Dr. Sekeres shared with us what he and his MDS colleagues are focusing their research on right now.

April 25, 2023

Dr. Chandhok is doing important research into improving drug efficacy for underserved populations.

April 18, 2023

The work Dr. Tinsley Vance is doing is important and will have a big impact on the way we look at patient decision making and our support of caregivers.

April 04, 2023

Immune system regulators are emerging as significant targets for immunotherapy in hematological malignancies.

March 07, 2023

BMT “was associated with an increased risk of subsequent malignant neoplasms of the gastrointestinal (GI) tract.”

January 31, 2023

During the 64th ASH Annual Meeting, Dr. Verma outlined the various inflammatory mediators that are elevated in MDS.

January 25, 2023

Venetoclax is a BCL-2 inhibitor, meaning it blocks the action of the BCL-2 protein that helps cancer cells survive and grow.

January 18, 2023

Many factors contribute to health inequity including access to care and health insurance, cost, and education

January 09, 2023

A new classification proposal for MDS.